Chris Lau
All posts from Chris Lau
Chris Lau in Value Stocks,

Gilead Sciences' Rough Patch will not Last

A one quarter event. One bad earnings report after several good ones in row.

Gilead Sciences will recover, back to $100 and above.

Perrigo Company plc (PRGO) is also on sale.

Valeant Pharma (VRX) is approaching value.

Allergan plc (AGN) is too inexpensive to ignore.

Agree or disagree?